Aurobindo to buy 7 oncology injectables from Spectrum Pharma

- The acquisition involves an upfront payment of $160 million in cash
- Acrotech Biopharma LLC, a wholly-owned subsidiary of Aurobindo Pharma USA Inc. will acquire the assets on a debt free and cash free basis